NASDAQ:HCAT

Health Catalyst (HCAT) Stock Forecast, Price & News

$10.12

+0.46 (+4.76%)

(As of 09/29/2023 ET)

Compare

Today's Range: $9.66
▼
$10.14
50-Day Range: $9.35
▼
$14.32
52-Week Range: $6.40
▼
$15.87

Volume: 916,574 shs
Average Volume: 369,554 shs
Market Capitalization: $576.44 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $14.55

Health Catalyst MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.56 Rating Score
Upside/Downside: 43.7% Upside
$14.55 Price Target
Short Interest: Healthy
1.79% of Shares Sold Short
Dividend Strength: N/A
Sustainability: -0.91
Upright™ Environmental Score
News Sentiment: 0.78
Based on 5 Articles This Week
Insider Trading: Selling Shares
$73,600 Sold Last Quarter
Proj. Earnings Growth: Growing
From ($0.93) to ($0.85) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.40 out of 5 stars

Medical Sector

203rd out of 972 stocks

Computer Programming, Data Processing, & Other Computer Related Industry

19th out of 61 stocks

3.3

Analyst's Opinion

Consensus Rating
Health Catalyst has received a consensus rating of Moderate Buy. The company's average rating score is 2.56, and is based on 5 buy ratings, 4 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $14.55, Health Catalyst has a forecasted upside of 43.7% from its current price of $10.12.
Amount of Analyst Coverage
Health Catalyst has only been the subject of 2 research reports in the past 90 days.

4.0

Short Interest

Percentage of Shares Shorted
1.79% of the outstanding shares of Health Catalyst have been sold short.
Short Interest Ratio / Days to Cover
Health Catalyst has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Health Catalyst has recently decreased by 1.92%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
Health Catalyst does not currently pay a dividend.
Dividend Growth
Health Catalyst does not have a long track record of dividend growth.

3.8

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Health Catalyst has received a 48.83% net impact score from Upright. Health Catalyst seems to create the most significant positive value in categories "Taxes", "Creating knowledge", and "Physical diseases". The positive contribution in the "Creating knowledge" impact category is mostly driven by its "Health data collection software", "Data analytics services", and "Drug discovery software" products. See details.
Environmental Sustainability
The Environmental Impact score for Health Catalyst is -0.91.

2.7

News and Social Media Coverage

News Sentiment
Health Catalyst has a news sentiment score of 0.78. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 5 news articles for Health Catalyst this week, compared to 2 articles on an average week.
MarketBeat Follows
2 people have added Health Catalyst to their MarketBeat watchlist in the last 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Health Catalyst insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $73,600.00 in company stock.
Percentage Held by Insiders
Only 2.70% of the stock of Health Catalyst is held by insiders.
Percentage Held by Institutions
86.63% of the stock of Health Catalyst is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Health Catalyst are expected to grow in the coming year, from ($0.93) to ($0.85) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Health Catalyst is -3.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Health Catalyst is -3.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Health Catalyst has a P/B Ratio of 1.30. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Health Catalyst (NASDAQ:HCAT) Stock

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company offers data operating system data platform for analytics, and application development and interoperability that provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications designed to analyze the problems faced across clinical and quality, population health, and financial and operational use cases. It also provides services expertise, which include data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.

HCAT Price History

30 days | 90 days | 365 days | Advanced Chart

HCAT Stock News Headlines

September 29, 2023 | americanbankingnews.com

Head to Head Contrast: Clikia (OTCMKTS:CLKA) versus Health Catalyst (NASDAQ:HCAT)

September 27, 2023 | finance.yahoo.com

Health Catalyst Pop Analyzer™ and Health Catalyst Care Flow™ Achieve NCQA Population Health Management Prevalidation Status

October 1, 2023 | Behind the Markets (Ad)

66,000% upside on tiny biotech?

The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.

September 27, 2023 | americanbankingnews.com

Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of "Moderate Buy" by Analysts

September 15, 2023 | nasdaq.com

Cantor Fitzgerald Reiterates Health Catalyst (HCAT) Overweight Recommendation

September 5, 2023 | finance.yahoo.com

Health Catalyst Recognized in Five Gartner® Hype Cycle™ Reports

August 29, 2023 | msn.com

Canaccord Genuity Maintains Health Catalyst (HCAT) Buy Recommendation

August 15, 2023 | finance.yahoo.com

Steven Cohen's Q2 2023 13F Filing Update: Top Trades and Portfolio Overview

October 1, 2023 | Behind the Markets (Ad)

66,000% upside on tiny biotech?

August 10, 2023 | finance.yahoo.com

Here’s Why Conestoga Micro Cap Strategy Sold Health Catalyst (HCAT)

August 9, 2023 | finanznachrichten.de

Health Catalyst, Inc.: Health Catalyst Reports Second Quarter 2023 Results

August 9, 2023 | finance.yahoo.com

Health Catalyst (HCAT) Reports Q2 Earnings: What Key Metrics Have to Say

August 8, 2023 | theglobeandmail.com

Health Catalyst's (NASDAQ:HCAT) Q2 Earnings Results: Revenue In Line With Expectations But Quarterly Guidance Underwhelms

August 8, 2023 | finance.yahoo.com

Health Catalyst Reports Second Quarter 2023 Results

August 8, 2023 | finance.yahoo.com

Health Catalyst Is Great Place To Work® Certified™ in India

August 8, 2023 | finance.yahoo.com

Health Catalyst (HCAT) Q2 Earnings and Revenues Surpass Estimates

July 30, 2023 | finance.yahoo.com

Health Catalyst (NASDAQ:HCAT) shareholders have endured a 61% loss from investing in the stock three years ago

July 28, 2023 | finance.yahoo.com

Steven Cohen Boosts Stake in Health Catalyst Inc

July 28, 2023 | finance.yahoo.com

Twistle by Health Catalyst Achieves HITRUST CSF® Certification

July 21, 2023 | markets.businessinsider.com

RBC Capital Sticks to Its Hold Rating for Health Catalyst (HCAT)

July 12, 2023 | finanznachrichten.de

Financialnewsmedia.com: Growing Number of Industries Realize the Urgency for Ransomware Protection

July 10, 2023 | markets.businessinsider.com

Health Catalyst (HCAT) Gets a Buy from Wells Fargo

June 28, 2023 | msn.com

Health Catalyst: Share Price Still Not Reflective Of Intrinsic Value

June 27, 2023 | finance.yahoo.com

Ohio Health Information Partnership Powers CliniSync with Health Catalyst

June 21, 2023 | seekingalpha.com

Health Catalyst: Recovery Won't Be Soon

May 15, 2023 | finance.yahoo.com

CEO & Director of Health Catalyst Picks Up 6.9% More Stock \

May 12, 2023 | msn.com

Guggenheim Downgrades Health Catalyst (HCAT)

See More Headlines

Receive HCAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter.

HCAT Company Calendar

Last Earnings: 8/08/2023
Today: 10/01/2023
Next Earnings (Estimated): 11/14/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Computer programming, data processing, & other computer related
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:HCAT
CUSIP: N/A
CIK: 1636422
Web: www.healthcatalyst.com
Phone: (801) 708-6800
Fax: N/A
Employees: 1,200
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $14.55
High Stock Price Forecast: $18.00
Low Stock Price Forecast: $8.00
Forecasted Upside/Downside: +43.7%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.56
Research Coverage: 9 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($2.68)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-137,400,000.00
Net Margins: -51.76%
Pretax Margin: -51.63%
Return on Equity: -16.49%
Return on Assets: -9.11%

Debt

Debt-to-Equity Ratio: 0.58
Current Ratio: 4.74
Quick Ratio: 4.74

Sales & Book Value

Annual Sales: $276.24 million
Price / Sales: 2.09
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $7.76 per share
Price / Book: 1.30

Miscellaneous

Outstanding Shares: 56,960,000
Free Float: 55,425,000
Market Cap: $576.44 million
Optionable: Not Optionable
Beta: 1.30

10 Best Stocks to Own in 2023

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio.

Get This Free Report

Key Executives

Mr. Daniel D. Burton (Age 48)
CEO & Director
Comp: $158.9k

Mr. Bryan Truman Hunt (Age 36)
Chief Financial Officer
Comp: $370.46k

Mr. Daniel H. Orenstein (Age 53)
Sr. Advisor
Comp: $356.56k

Mr. Kevin Freeman (Age 50)
Chief Commercial Officer
Comp: $405.9k

Ms. Anne Marie Bickmore (Age 60)
COO & Chief Product Officer

Mr. Jason Alger (Age 39)
Chief Accounting Officer

Mr. Dave Ross
Chief Technology Officer

Mr. Adam Brown
Sr. VP of Investor Relations and Financial Planning & Analysis

Mr. Benjamin Landry
Gen. Counsel & Sec. of the Board

Ms. Tarah Neujahr Bryan
Chief Marketing & Communications Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

HCAT Stock - Frequently Asked Questions

Should I buy or sell Health Catalyst stock right now?: 9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Health Catalyst in the last year. There are currently 4 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" HCAT shares.
View HCAT analyst ratings or view top-rated stocks.
What is Health Catalyst's stock price forecast for 2023?: 9 equities research analysts have issued 1 year target prices for Health Catalyst's stock. Their HCAT share price forecasts range from $8.00 to $18.00. On average, they expect the company's share price to reach $14.55 in the next twelve months. This suggests a possible upside of 43.7% from the stock's current price.
View analysts price targets for HCAT or view top-rated stocks among Wall Street analysts.
How have HCAT shares performed in 2023?: Health Catalyst's stock was trading at $10.63 at the start of the year. Since then, HCAT stock has decreased by 4.8% and is now trading at $10.12.
View the best growth stocks for 2023 here.
When is Health Catalyst's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our HCAT earnings forecast.
How were Health Catalyst's earnings last quarter?: Health Catalyst, Inc. (NASDAQ:HCAT) announced its earnings results on Tuesday, August, 8th. The company reported ($0.21) earnings per share for the quarter, beating the consensus estimate of ($0.30) by $0.09. The firm earned $73.21 million during the quarter, compared to analysts' expectations of $72.67 million. Health Catalyst had a negative trailing twelve-month return on equity of 16.49% and a negative net margin of 51.76%.
What ETFs hold Health Catalyst's stock?: ETFs with the largest weight of Health Catalyst (NASDAQ:HCAT) stock in their portfolio include Fidelity Digital Health ETF (FDHT), ROBO Global Healthcare Technology and Innovation ETF (HTEC), SPDR FactSet Innovative Technology ETF (XITK) and First Trust Nasdaq Lux Digital Health Solutions ETF (EKG).iShares U.S. Healthcare Providers ETF (IHF).
What guidance has Health Catalyst issued on next quarter's earnings?: Health Catalyst updated its third quarter 2023 earnings guidance on Tuesday, August, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $70.20 million-$74.20 million, compared to the consensus revenue estimate of $72.86 million.
What is Dan Burton's approval rating as Health Catalyst's CEO?: 501 employees have rated Health Catalyst Chief Executive Officer Dan Burton on Glassdoor.com. Dan Burton has an approval rating of 99% among the company's employees. This puts Dan Burton in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 83.0% of employees surveyed would recommend working at Health Catalyst to a friend.

What other stocks do shareholders of Health Catalyst own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Health Catalyst investors own include NVIDIA (NVDA), Salesforce (CRM), Alteryx (AYX), Walt Disney (DIS), DocuSign (DOCU), Block (SQ), Slack Technologies (WORK), ServiceNow (NOW), Marvell Technology (MRVL) and PayPal (PYPL).
When did Health Catalyst IPO?: (HCAT) raised $129 million in an IPO on Thursday, July 25th 2019. The company issued 6,000,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and William Blair served as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers.
What is Health Catalyst's stock symbol?: Health Catalyst trades on the NASDAQ under the ticker symbol "HCAT."
How do I buy shares of Health Catalyst?: Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Health Catalyst's stock price today?: One share of HCAT stock can currently be purchased for approximately $10.12.
How much money does Health Catalyst make?: Health Catalyst (NASDAQ:HCAT) has a market capitalization of $576.44 million and generates $276.24 million in revenue each year. The company earns $-137,400,000.00 in net income (profit) each year or ($2.68) on an earnings per share basis.
How many employees does Health Catalyst have?: The company employs 1,200 workers across the globe.
How can I contact Health Catalyst?: Health Catalyst's mailing address is 3165 MILLROCK DRIVE SUITE 400, SALT LAKE CITY UT, 84121. The official website for the company is www.healthcatalyst.com. The company can be reached via phone at (801) 708-6800 or via email at ir@healthcatalyst.com.

This page (NASDAQ:HCAT) was last updated on 10/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Health Catalyst (HCAT) Stock Forecast, Price & News

Health Catalyst MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Health Catalyst (NASDAQ:HCAT) Stock

HCAT Price History

HCAT Stock News Headlines

HCAT Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

HCAT Stock - Frequently Asked Questions

Overall MarketRank^™